195 related articles for article (PubMed ID: 33247181)
1. The PAR2 inhibitor I-287 selectively targets Gα
Avet C; Sturino C; Grastilleur S; Gouill CL; Semache M; Gross F; Gendron L; Bennani Y; Mancini JA; Sayegh CE; Bouvier M
Commun Biol; 2020 Nov; 3(1):719. PubMed ID: 33247181
[TBL] [Abstract][Full Text] [Related]
2. Gβγ signaling to the chemotactic effector P-REX1 and mammalian cell migration is directly regulated by Gα
Cervantes-Villagrana RD; Adame-García SR; García-Jiménez I; Color-Aparicio VM; Beltrán-Navarro YM; König GM; Kostenis E; Reyes-Cruz G; Gutkind JS; Vázquez-Prado J
J Biol Chem; 2019 Jan; 294(2):531-546. PubMed ID: 30446620
[TBL] [Abstract][Full Text] [Related]
3. Receptor selectivity between the G proteins Gα
Mackenzie AE; Quon T; Lin LC; Hauser AS; Jenkins L; Inoue A; Tobin AB; Gloriam DE; Hudson BD; Milligan G
FASEB J; 2019 Apr; 33(4):5005-5017. PubMed ID: 30601679
[TBL] [Abstract][Full Text] [Related]
4. Prostaglandin F2α and angiotensin II type 1 receptors exhibit differential cognate G protein coupling regulation.
Sedki D; Cho A; Cao Y; Nikolajev L; Atmuri NDP; Lubell WD; Laporte SA
J Biol Chem; 2022 Sep; 298(9):102294. PubMed ID: 35872018
[TBL] [Abstract][Full Text] [Related]
5. Relative contribution of G-protein-coupled pathways to protease-activated receptor-mediated Akt phosphorylation in platelets.
Kim S; Jin J; Kunapuli SP
Blood; 2006 Feb; 107(3):947-54. PubMed ID: 16223779
[TBL] [Abstract][Full Text] [Related]
6. G protein-dependent basal and evoked endothelial cell vWF secretion.
Rusu L; Andreeva A; Visintine DJ; Kim K; Vogel SM; Stojanovic-Terpo A; Chernaya O; Liu G; Bakhshi FR; Haberichter SL; Iwanari H; Kusano-Arai O; Suzuki N; Hamakubo T; Kozasa T; Cho J; Du X; Minshall RD
Blood; 2014 Jan; 123(3):442-50. PubMed ID: 24081657
[TBL] [Abstract][Full Text] [Related]
7. Thrombin protease-activated receptor-1 signals through Gq- and G13-initiated MAPK cascades regulating c-Jun expression to induce cell transformation.
Marinissen MJ; Servitja JM; Offermanns S; Simon MI; Gutkind JS
J Biol Chem; 2003 Nov; 278(47):46814-25. PubMed ID: 12954641
[TBL] [Abstract][Full Text] [Related]
8. Discovery of 2-aryloxy-4-amino-quinazoline derivatives as novel protease-activated receptor 2 (PAR2) antagonists.
Cho NC; Cha JH; Kim H; Kwak J; Kim D; Seo SH; Shin JS; Kim T; Park KD; Lee J; No KT; Kim YK; Lee KT; Pae AN
Bioorg Med Chem; 2015 Dec; 23(24):7717-27. PubMed ID: 26631441
[TBL] [Abstract][Full Text] [Related]
9. Receptor-dependent RhoA activation in G12/G13-deficient cells: genetic evidence for an involvement of Gq/G11.
Vogt S; Grosse R; Schultz G; Offermanns S
J Biol Chem; 2003 Aug; 278(31):28743-9. PubMed ID: 12771155
[TBL] [Abstract][Full Text] [Related]
10. Pepducin targeting the C-X-C chemokine receptor type 4 acts as a biased agonist favoring activation of the inhibitory G protein.
Quoyer J; Janz JM; Luo J; Ren Y; Armando S; Lukashova V; Benovic JL; Carlson KE; Hunt SW; Bouvier M
Proc Natl Acad Sci U S A; 2013 Dec; 110(52):E5088-97. PubMed ID: 24309376
[TBL] [Abstract][Full Text] [Related]
11. N-linked glycosylation of protease-activated receptor-1 at extracellular loop 2 regulates G-protein signaling bias.
Soto AG; Smith TH; Chen B; Bhattacharya S; Cordova IC; Kenakin T; Vaidehi N; Trejo J
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):E3600-8. PubMed ID: 26100877
[TBL] [Abstract][Full Text] [Related]
12. Differential association modes of the thrombin receptor PAR1 with Galphai1, Galpha12, and beta-arrestin 1.
Ayoub MA; Trinquet E; Pfleger KD; Pin JP
FASEB J; 2010 Sep; 24(9):3522-35. PubMed ID: 20410441
[TBL] [Abstract][Full Text] [Related]
13. The regulators of G protein signaling RGS16 and RGS18 inhibit protease-activated receptor 2/Gi/o signaling through distinct interactions with Gα in live cells.
Kim K; Lee J; Ghil S
FEBS Lett; 2018 Sep; 592(18):3126-3138. PubMed ID: 30117167
[TBL] [Abstract][Full Text] [Related]
14. Agonism, Antagonism, and Inverse Agonism Bias at the Ghrelin Receptor Signaling.
M'Kadmi C; Leyris JP; Onfroy L; Galés C; Saulière A; Gagne D; Damian M; Mary S; Maingot M; Denoyelle S; Verdié P; Fehrentz JA; Martinez J; Banères JL; Marie J
J Biol Chem; 2015 Nov; 290(45):27021-27039. PubMed ID: 26363071
[TBL] [Abstract][Full Text] [Related]
15. A Potent Antagonist of Protease-Activated Receptor 2 That Inhibits Multiple Signaling Functions in Human Cancer Cells.
Jiang Y; Yau MK; Lim J; Wu KC; Xu W; Suen JY; Fairlie DP
J Pharmacol Exp Ther; 2018 Feb; 364(2):246-257. PubMed ID: 29263243
[TBL] [Abstract][Full Text] [Related]
16. Protein kinase D and Gβγ mediate sustained nociceptive signaling by biased agonists of protease-activated receptor-2.
Zhao P; Pattison LA; Jensen DD; Jimenez-Vargas NN; Latorre R; Lieu T; Jaramillo JO; Lopez-Lopez C; Poole DP; Vanner SJ; Schmidt BL; Bunnett NW
J Biol Chem; 2019 Jul; 294(27):10649-10662. PubMed ID: 31142616
[TBL] [Abstract][Full Text] [Related]
17. Human airway trypsin-like protease induces mucin5AC hypersecretion via a protease-activated receptor 2-mediated pathway in human airway epithelial cells.
Liu C; Li Q; Zhou X; Kolosov VP; Perelman JM
Arch Biochem Biophys; 2013 Jul; 535(2):234-40. PubMed ID: 23602830
[TBL] [Abstract][Full Text] [Related]
18. Live cell optical assay for precise characterization of receptors coupling to Gα12.
Masuho I; Skamangas NK; Martemyanov KA
Basic Clin Pharmacol Toxicol; 2020 Jun; 126 Suppl 6(Suppl 6):88-95. PubMed ID: 30916867
[TBL] [Abstract][Full Text] [Related]
19. Protease activated receptor 2 (PAR2) modulators: a patent review (2010-2015).
Yau MK; Lim J; Liu L; Fairlie DP
Expert Opin Ther Pat; 2016; 26(4):471-83. PubMed ID: 26936077
[TBL] [Abstract][Full Text] [Related]
20. Agonist-induced formation of unproductive receptor-G
Okashah N; Wright SC; Kawakami K; Mathiasen S; Zhou J; Lu S; Javitch JA; Inoue A; Bouvier M; Lambert NA
Proc Natl Acad Sci U S A; 2020 Sep; 117(35):21723-21730. PubMed ID: 32817560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
